If you want a no fuss, easy-to-use cordless vacuum cleaner that does a stellar cleaning job, then the Vax HomePro is worth knowing about. It has a simple display and controls, and glides across ...
Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. The 16.4% increase—at grant value—came ...
In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $30.00. See what stocks are receiving Strong ...
Bullish option flow detected in Moderna (MRNA) with 25,737 calls trading, 1.2x expected, and implied vol increasing almost 4 points to 82.07%. Jan-26 35 calls and 3/7 weekly 35 calls are the most ...
Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said. The review is part of a ...
HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...
The top-selling Vax SpotWash Duo Spot Cleaner is currently available for £89.99, down from its original price of £139.99, offering a saving of £50.99. This portable device tackles spills and ...
Amazon has slashed the price of the Vax Blade 4 Pet Cordless Vacuum, which is specially designed to tackle pet hair. Originally priced at £259.99, it's now available for £135.01 – a saving of ...
FIRST ON FOX: Department of Health and Human Services Secretary Robert F. Kennedy Jr. has paused a multimillion-dollar contract from the Biden administration to create a new COVID-19 vaccine, Fox ...
Investors with a lot of money to spend have taken a bullish stance on Moderna MRNA. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...
Moderna Inc.’s stock erased early losses to gain more than 3% on Friday, after the biotech company posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results